Inmune Bio (INMB)
NASDAQ:INMB
Inmune Bio (INMB) Ownership Overview
11.17%
Insiders
4.83% Mutual Funds
2.33% Other Institutional Investors
5.71% ETFs
75.96% Public Companies and
Individual Investors
The ownership structure of Inmune Bio (INMB) stock is a mix of institutional, retail, and individual investors. Approximately 12.87% of the company’s stock is owned by Institutional Investors, 11.17% is owned by Insiders, and 75.96% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,510,806 | Insider | 5.68% | 2,039,588 | |
| 1,285,869 | Insider | 4.84% | 1,735,923 | |
| 803,927 | Institution | 3.02% | 1,085,301 | |
| 687,015 | Institution | 2.58% | 927,470 | |
| 661,172 | Institution | 2.49% | 892,582 | |
| 238,672 | Institution | 0.90% | 322,207 | |
| 126,416 | Institution | 0.48% | 170,662 | |
| 122,296 | Institution | 0.46% | 165,100 | |
| 82,187 | Insider | 0.31% | 110,952 | |
| 71,603 | Insider | 0.27% | 96,664 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 687,015 | Institution | 2.58% | 927,470 | |
| 238,672 | Institution | 0.90% | 322,207 | |
| 126,416 | Institution | 0.48% | 170,662 | |
| 122,296 | Institution | 0.46% | 165,100 | |
| 41,825 | Institution | 0.16% | 56,464 | |
| 23,364 | Institution | 0.09% | 31,541 | |
| 16,518 | Institution | 0.06% | 22,299 | |
| 10,614 | Institution | 0.04% | 14,329 | |
| 4,900 | Institution | 0.02% | 6,615 | |
| 2,925 | Institution | 0.01% | 3,949 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 490,268 | Institution | 1.84% | 779,526 | |
| 399,930 | Institution | 1.50% | 523,908 | |
| 203,786 | Institution | 0.77% | 266,960 | |
| 196,747 | Institution | 0.74% | 312,828 | |
| 100,022 | Institution | 0.38% | 129,028 | |
| 57,456 | Institution | 0.22% | 75,267 | |
| 18,944 | Institution | 0.07% | 24,438 | |
| 9,771 | Institution | 0.04% | 12,800 | |
| 2,015 | Institution | <0.01% | 2,640 | |
| 895 | Institution | <0.01% | 1,208 |
FAQ
Who Owns Inmune Bio (INMB)?
According to the latest TipRanks data, approximately 2.33% of the company's stock is held by institutional investors, 11.17% is held by insiders, and 75.96% is held by retail investors.
What percentage of Inmune Bio (INMB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.33% of Inmune Bio (INMB) stock is held by institutional investors.
What percentage of Inmune Bio (INMB) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.96% of Inmune Bio (INMB) stock is held by retail investors.
Who owns the most shares of Inmune Bio (INMB)?
Mark William Lowdell owns the most shares of Inmune Bio (INMB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.